Organisation › Details

Lead Discovery Center GmbH (LDC), LDC Biologics Branch Munich

The Lead Discovery Center GmbH (LDC) has established a branch - LDC Biologics - in the Munich Biocluster. While the team in Dortmund focuses on chemical compounds (small molecules), in Munich the emphasis will be on the development of therapeutic antibodies. LDC Biologics will produce, optimise and humanise innovative antibodies according to industrial standards in close cooperation with partners from academia and therefore connecting academic research and industrial drug discovery. The Munich team, under the management of Dr. Johannes Bange, can resort to more than 15 years of experience in the pre-clinical and clinical development of therapeutic antibodies. With this branch office, LDC is also expanding its long-standing expertise in the pharmaceutical drug discovery with partners from academia and industry to include the development of therapeutic antibodies. This allows for the use of technologies and methods complying with the highest quality standards and industrial best practices at a very early project stage and creates a sustainable transfer solution for excellent innovative ideas from academia and the industry. In addition, the entire drug discovery value chain at the Munich site is supported by LDC´s well-proven global pharmaceutical and investor network through licencing and/or a spin-off of new companies. The new site of the antibody group is in direct proximity to the Martinsried Biotech Campus, which connects academic basic research and applied development. *

 

Period Start 2018-04-23 established
  Group Max Planck Society for the Advancement of Science
Products Industry lead generation (service)
  Industry 2 biopharmaceutical
     
Region Region Martinsried
  Country Germany
  City n. a. Martinsried
    Address record changed: 2018-04-24
     
Basic data Employees n. a.
     
    * Document for �About Section�: Lead Discovery Center GmbH. (4/23/18). "Press Release: LDC – New Branch for Development of Therapeutic Antibodies in Munich". Dortmund & Munich.
     
   
Record changed: 2018-04-24

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

More documents for Max Planck Society for the Advancement of Science


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x113px




» top